Glaxosmithkline Pharmaceuticals Ltd - Stock Price

As on21 Sep 2020 03:29 PM
  • BSE : 500660
  • ISIN CODE : INE159A01016
  • Industry : Pharmaceuticals & Drugs
  • House : Glaxosmithkline - MNC
Glaxosmithkline Pharmaceuticals Ltd is not traded on BSE/NSE
-1.58 %-26.9
-1.62 %-27.6

Balance Sheet

Parameter MAR 20  MAR 19  YoY %Change
Share Capital1694.061694.060.00
    Equity - Authorised1800.001800.000.00
    Equity - Issued1694.151694.150.00
    Equity Paid Up1694.061694.060.00
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value10.0010.000.00
Share Warrants & Outstandings0.000.000.00
Total Reserves16511.9919704.23-16.20
    Securities Premium0.000.000.00
    Capital Reserves17.1017.100.00
    Profit & Loss Account Balance8755.1811907.70-26.47
    General Reserves7785.037785.030.00
    Other Reserves-45.32-5.59-710.86
Reserve excluding Revaluation Reserve16511.9919704.23-16.20
Revaluation reserve0.000.000.00
Shareholder's Funds18206.0521398.29-14.92
Minority Interest0.000.000.00
Long-Term Borrowings0.000.000.00
Secured Loans0.000.000.00
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks0.000.000.00
    Term Loans - Institutions0.000.000.00
    Other Secured0.000.000.00
Unsecured Loans0.241.77-86.44
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.
    Loans - Others0.000.000.00
    Other Unsecured Loan0.241.77-86.44
Deferred Tax Assets / Liabilities-1104.86-622.22-77.57
    Deferred Tax Assets1277.25863.3947.93
    Deferred Tax Liability172.38241.18-28.53
Other Long Term Liabilities289.1022.081209.23
Long Term Trade Payables0.000.000.00
Long Term Provisions31240.9529202.056.98
Total Non-Current Liabilities30425.4328603.696.37
Current LiabilitiesNANANA
Trade Payables3575.854058.15-11.88
    Sundry Creditors3575.854058.15-11.88
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities2284.568027.11-71.54
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers37.9644.27-14.27
    Interest Accrued But Not Due0.000.000.00
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities2246.607982.84-71.86
Short Term Borrowings0.000.000.00
    Secured ST Loans repayable on Demands0.000.000.00
    Working Capital Loans- Sec0.000.000.00
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans0.000.000.00
Short Term Provisions17832.6815955.4011.77
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax15064.2815031.790.22
    Provision for post retirement benefits32.6121.4751.93
    Preference Dividend0.000.000.00
    Other Provisions2735.79902.14203.26
Total Current Liabilities23693.0928040.66-15.50
Total Liabilities72324.5778042.64-7.33
Gross Block14523.515590.54159.79
Less: Accumulated Depreciation6957.611290.62439.09
Less: Impairment of Assets0.000.000.00
Net Block7565.904299.9375.95
Lease Adjustment A/c0.000.000.00
Capital Work in Progress1201.2210026.44-88.02
Non Current Investments14.9316.94-11.84
Long Term Investment14.9316.94-11.84
Long Term Loans & Advances32271.5030028.837.47
Other Non Current Assets71.6878.42-8.59
Total Non-Current Assets41125.2344450.55-7.48
Current Assets Loans & AdvancesNANANA
Currents Investments0.000.000.00
    Raw Materials764.791155.39-33.81
    Work-in Progress307.26220.9039.10
    Finished Goods923.831740.68-46.93
    Packing Materials0.000.000.00
    Stores  and Spare34.2032.545.11
    Other Inventory2800.251715.4363.24
Sundry Debtors998.011204.87-17.17
    Debtors more than Six months0.000.000.00
    Debtors Others1178.111357.57-13.22
Cash and Bank10832.0311713.46-7.52
    Cash in hand0.000.000.00
    Balances at Bank10197.8411640.81-12.40
    Other cash and bank balances634.1972.65773.00
Other Current Assets485.791123.02-56.74
    Interest accrued on Investments232.22224.943.24
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans0.000.000.00
    Prepaid Expenses117.89111.305.92
    Other current_assets135.68786.78-82.76
Short Term Loans and Advances14053.1814685.80-4.31
    Advances recoverable in cash or in kind170.30302.22-43.65
    Advance income tax and TDS13450.5213497.47-0.35
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances432.36886.11-51.21
Total Current Assets31199.3333592.09-7.12
Net Current Assets (Including Current Investments)7506.245551.4335.21
Miscellaneous Expenses not written off0.000.000.00
Total Assets72324.5778042.64-7.33
Contingent Liabilities4747.735340.12-11.09
Total Debt1.775.83-69.64
Book Value107.47126.31-14.92
Adjusted Book Value107.47126.31-14.92

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1698.95. Its current market capitalisation stands at Rs 28749.05 Cr. In the latest quarter, company has reported Gross Sales of Rs. 32243.81 Cr and Total Income of Rs.33033.93 Cr. The company's management includes S Maheshwari, S Williams, P Thakur, D Sundaram, A N Roy, R Krishnaswamy, N Kaviratne ( C B E ), PV Bhide, S Venkatesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

Latest News